Cefdinir Oral capsule 300mg Information - Conditions, Pregnancy, ingredients
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

Cefdinir: Oral capsule (300mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Most Commonly Used
Drug Image file DrugItem_11884.JPG
Cefdinir 300mg Cap
Lupin Pharmaceuticals
Pill Identification: LUPIN LUPIN CEFDINIR CEFDINIR 
Drug Image file DrugItem_9491.JPG
Cefdinir 300mg Cap
Sandoz Inc
Pill Identification: Sandoz 663 Sandoz 663 
Drug Image file DrugItem_9628.JPG
Cefdinir 300mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: 93 3160 93 3160 
Drug Image file DrugItem_13425.JPG
Cefdinir 300mg Cap
Northstar Rx LLC
Pill Identification: C 300 

What is this Medicine?

CEFDINIR (SEF di ner) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

Similar Brand Name Drugs : Omnicef: Oral capsule(300mg)
CVS/pharmacy Patient Statistics for Cefdinir: Oral capsule(300mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Cefdinir 300mg Capsule

NDC: 681800711
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumonia, Tonsillitis, Skin And Skin Structure Infections, Pharyngitis, Sinusitis, Otitis Media, Bronchitis, Community-acquired Pneumonia

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Cefdinir 300mg Capsule
Drug Image file DrugItem_11884.JPG
Lupin Pharmaceuticals
Pill Identification: LUPIN LUPIN CEFDINIR CEFDINIR 
Shape: capsule
Color: blue,purple

Reported Side Effects for Cefdinir 300mg Capsule

No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Low Kidney Function Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Eosinophilic Pneumonia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Not Breathing Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Ulcer Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pancytopenia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Melena Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Uncontrolled Movements Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Rash Of Red Skin Bumps Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Colon Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Disseminated Intravascular Coagulation (DIC) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Phosphate Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Low Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pseudomembranous Colitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Bowel Obstruction Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
0.2-3.0%*
Severity: MILD
Onset: EARLY
Yeast Infection Incidence:
0.2-4.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Discharge Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Hyperkinesis Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
0.2-0.7%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Itching Incidence:
0.2%*
Severity: MILD
Onset: RAPID
Constipation Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
0.3%*
Severity: MILD
Onset: DELAYED
Vaginal Infection Incidence:
0.3-1.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
0.7-1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
0.7%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
0.8-1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
0.9-3.0%*
Severity: MILD
Onset: EARLY
Protein In The Urine Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
8.0-15.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cefdinir

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.